188 related articles for article (PubMed ID: 3777958)
1. [Detection of DU-PAN-2 antigen (pancreatic cancer-associated antigen) in sera of patients with cancer of the digestive tract].
Takami H; Furuuchi T; Ogata Y; Abe O
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3207-14. PubMed ID: 3777958
[TBL] [Abstract][Full Text] [Related]
2. [Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers].
Takemori Y; Sawabu N; Satomura Y; Ohta H; Watanabe H; Okai T; Mai M; Hattori N; Akiyama T; Hashimoto T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):119-26. PubMed ID: 3541791
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of serum DU-PAN-2 surveyed by solid-phase sandwich EIA for DU-PAN-2].
Ishii M; Urabe T; Seino Y
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1860-5. PubMed ID: 3296960
[TBL] [Abstract][Full Text] [Related]
4. Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients.
Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
Cancer Res; 1988 Mar; 48(6):1435-8. PubMed ID: 3162196
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of tumor-associated antigen of the digestive tract by monoclonal antibody].
Imai K; Hinoda Y; Yachi A
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2185-90. PubMed ID: 3606145
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
[TBL] [Abstract][Full Text] [Related]
7. [Serological test of carbohydrate antigen CA50 in patients with cancer of the digestive tract].
Takami H; Furuuchi T; Ogata Y; Abe O
Gan To Kagaku Ryoho; 1987 Feb; 14(2):495-501. PubMed ID: 3468885
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers of pancreatic cancer].
Takami H; Hishinuma S; Shintoku J; Furuuchi T; Ogata Y; Abe O
Gan To Kagaku Ryoho; 1985 Feb; 12(2):212-9. PubMed ID: 3855615
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic usefulness of serum levels of pancreatic oncofetal antigen (POA) and CA 19-9 in pancreatic cancers: monitoring of postoperative recurrences].
Takami H; Hishinuma S; Shintoku J; Ogata Y; Abe O
Gan No Rinsho; 1985 May; 31(6 Suppl):631-7. PubMed ID: 3861883
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
Ohshio G; Manabe T; Watanabe Y; Endo K; Kudo H; Suzuki T; Tobe T
Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
[TBL] [Abstract][Full Text] [Related]
11. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.
Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ
Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas.
Borowitz MJ; Tuck FL; Sindelar WF; Fernsten PD; Metzgar RS
J Natl Cancer Inst; 1984 May; 72(5):999-1005. PubMed ID: 6371347
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinoma.
Tempero M; Takasaki H; Uchida E; Takiyama Y; Colcher D; Metzgar RS; Pour PM
Am J Surg Pathol; 1989; 13 Suppl 1():89-95. PubMed ID: 2699170
[TBL] [Abstract][Full Text] [Related]
14. Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers.
Sawabu N; Toya D; Takemori Y; Hattori N; Fukui M
Int J Cancer; 1986 May; 37(5):693-6. PubMed ID: 3457770
[TBL] [Abstract][Full Text] [Related]
15. Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2.
Lan MS; Finn OJ; Fernsten PD; Metzgar RS
Cancer Res; 1985 Jan; 45(1):305-10. PubMed ID: 3965141
[TBL] [Abstract][Full Text] [Related]
16. [Clinical investigation of carbohydrate antigen CA-50].
Ishii M; Abe O; Okura H; Okazaki N; Kawai T; Saito Y; Sawabu N; Takamizawa Y; Takeuchi T; Niitani H
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2548-55. PubMed ID: 3304170
[TBL] [Abstract][Full Text] [Related]
17. Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract.
Harmenberg U; Wahren B; Wiechel KL
Cancer Res; 1988 Apr; 48(7):1985-8. PubMed ID: 3349472
[TBL] [Abstract][Full Text] [Related]
18. [Carbohydrate antigen CA 19-9: value in pancreatic pathology].
Venot J; Vincent D; Gainant A; Descottes B; Cessot F; Beck C
Gastroenterol Clin Biol; 1986 Mar; 10(3):208-10. PubMed ID: 3460925
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal cancer-associated antigen in immunoperoxidase assay.
Atkinson BF; Ernst CS; Herlyn M; Steplewski Z; Sears HF; Koprowski H
Cancer Res; 1982 Nov; 42(11):4820-3. PubMed ID: 6751528
[TBL] [Abstract][Full Text] [Related]
20. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
Kim HJ; Kim MH; Myung SJ; Lim BC; Park ET; Yoo KS; Seo DW; Lee SK; Min YI
Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
